Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Lloyd Minor

At a glance: Lloyd Minor is Director at Biogen (BIIB). Their latest SEC Form 4, filed Aug 5, 2026, reported a sale of $121K. On file: 0 purchase lines ($0) and 2 sale lines ($240K).

Disclosed holdings: about $671K of BIIB stock: 2,689 shares reported on their latest Form 4 (filed Aug 5, 2026), valued at the Nov 20, 2026 close of $249.69. This counts only BIIB shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Biogen Inc. (BIIB)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $240K

Lloyd Minor's InsiderPrint

2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Lloyd Minor: 2 trades, 2026 to 20262026: 0 buys, 2 sales
  • Bump outward: a purchase (0)
  • Dent inward: a sale (2)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
Aug 5SEC BIIBBiogen Inc. Sell Plan 5933,282 held (−15%) $203.34 $121K +22.8%
Aug 5SEC BIIBBiogen Inc. Sell Plan 5932,689 held (−18%) $200.96 $119K +24.2%
  • Sell

    Director Lloyd Minor sold $121K of BIIB at $203.34 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Lloyd Minor sold $119K of BIIB at $200.96 — pre-scheduled 10b5-1 plan sale.

Follow Lloyd Minor

Get one email when Lloyd Minor files a new purchase or sale. Free.

At most one email a day about Lloyd Minor, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.